C
IHI icon

CEDRUS’s iShares US Medical Devices ETF IHI Stock Holding History

CEDRUS’s Portfolio IHI Stock Details IHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,634
Closed -$222K – 150
2022
Q1 		$222K Sell
3,634
-485
-12% -$28.9K 0.2% 132
2021
Q4 		$271K Buy
+4,119
New +$264K 0.26% 114

Other funds holding IHI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

CEDRUS's IHI Position: Q2 2022 in Review

CEDRUS sold out of iShares US Medical Devices ETF (IHI) in Q2 2022, closing a stake of 3,634 shares — an estimated $222K sold.

CEDRUS first reported a position in IHI in Q4 2021 and held it in 2 quarters. The position peaked at $271K in Q4 2021. 593 funds tracked by Wall St. Rank hold IHI as of Q2 2022.

  • CEDRUS reported no remaining iShares US Medical Devices ETF position as of Q2 2022 after selling out during the quarter.
  • CEDRUS sold 3,634 iShares US Medical Devices ETF shares in Q2 2022, an estimated $222K.
  • CEDRUS first reported a position in iShares US Medical Devices ETF in Q4 2021 and held it in 2 quarters.
  • CEDRUS's iShares US Medical Devices ETF position peaked at $271K in Q4 2021.
  • 593 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2022.

Based on CEDRUS's 13F filing for Q2 2022, filed 19 Jan 2024.